Show Advanced FiltersHide Advanced Filters
Use filters to refine the search results.
ResetAdd New FilterSearch
Now showing items 1-7 of 7
Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma
Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas.
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.
Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases.
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth